FeRivaFA description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

FeRivaFA

Avion Pharmaceuticals, LLC

FeRivaFAFA


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Iron Supplement

110 mg Dual-Iron Delivery with Quatrefolic

Rx Only Dietary Supplement

DESCRIPTION: FeRivaFA is a prescription iron supplement. FeRivaFA™ is a red gel capsule.

Supplement Facts
Serving Size: 1 Capsule
Each Capsule Contains:
Iron
(as Ferrous Bis-glycinate Chelate -
Ferrochel®and Carbonyl Iron - Ferronyl®)
110 mg
Vitamin C 175 mg
Folate
(as 1.1 mg Quatrefolic®((6S)-5,-
methyltetrahydrofolate glucosamine salt* CAS
1181972-37-1) molar equivalent to 600 mcg of
Folic acid) (Folic acid, USP 400 mcg)
1 mg
Vitamin B12
(as cyanocobalamin)
12 mcg
Copper Oxide 1.5 mg
Docusate Sodium 50 mg

OTHER INGREDIENTS: Microcrystalline Cellulose, Gelatin, Magnesium Stearate, Silicon Dioxide, Titanium Dioxide and FD&C Red 40.

Uses

INDICATIONS: FeRivaFA is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.

CONTRAINDICATIONS: FeRivaFA is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. While prescribing this nutritional supplement for pregnant women, nursing mothers or for women prior to conception, their medical condition and other drugs, herbs and/or supplements consumption should be considered.

ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

DOSAGE AND ADMINISTRATION: One capsule daily with or without food or as prescribed by your healthcare provider.

HOW SUPPLIED: In child-resistant bottles of 30 capsules (75854-310-30) and as a sample in a 3-dose unit pack (75854-310-03). The listed product numbers are not National Drug Codes, but have instead been formatted to comply with standard industry practice for pharmacy computer systems.

STORAGE: Store between 20°- 25°C (68°- 77°F)

MANUFACTURED FOR:
Avion Pharmaceuticals, LLC
Atlanta, GA 30022
1-888-61-AVION

Ferronyl® is a registered trademark of ISP Investments, Inc. Ferrochel® is a registered trademark of Albion Laboratories, Inc. covered by U.S. Patents 6,716,814 & 7,838,042. Quatrefolic® is a registered trademark of Gnosis, SpA,covered by one or more claims of U.S. Patent # 7,947,662 CAS# 1181972-37-1

Rev. 0114

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

75854-310-30

FeRivaFA

Iron Supplement

110 mg Dual-Iron Delivery

with Quatrefolic

30 Capsules

Rx Only

Avion
PHARMACEUTICALS

FeRivaFA

FeRivaFA

ferrous bisglycinate, ascorbic acid, folic acid, cyanocobalamin, biotin, cupric oxide and docusate sodium CAPSULE, GELATIN COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:75854-310
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ferrous bisglycinate FERROUS CATION 110 mg
ASCORBIC ACID ASCORBIC ACID 175 mg
FOLIC ACID FOLIC ACID 1 mg
Cyanocobalamin CYANOCOBALAMIN 12 ug
BIOTIN 300 ug
CUPRIC OXIDE CUPRIC CATION 1 mg
DOCUSATE SODIUM DOCUSATE 50 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
GELATIN
MAGNESIUM STEARATE
SILICON DIOXIDE
titanium dioxide
water
FD&C RED NO. 40

Product Characteristics

Color Size Shape
RED 22 mm CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:75854-310-30 30 in 1 BOTTLE
2 NDC:75854-310-03 3 in 1 PACKET

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2014-01-02


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.